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Abstract The societal monetary burden of cysticercosis in the Eastern Cape Province, South
Africa, Honduras, India and the United States of America were estimated. Data on the frequency
of infection and on associated morbidity in both human and pig populations and their costs were
collected. Decision trees were used to assess the frequency of medical care and loss of value of
pigs with their monetary impact. All results are in 2004 US$. The societal monetary cost of T. soli-
um cysticercosis was estimated to US$13.4 million (95% CI: US$45.3 million-US$262.3 million) in
India, US$20.0 million (US$6.2 million-US$37.6 million) in Honduras, US$24.8 million (95% CI =
$10.5 million, $49.0 million) in the Eastern Cape Province, and US$3.1 million (95% CI $1.2 mil-
lion, $6.4 million), in the United States. Porcine cysticercosis is a preventable infection that pro-
duces a very important monetary burden for some regions of the world. 
Introduction Neurocysticercosis (NCC), infection of the human brain by the larvae of the zoonotic
parasite Taenia solium, is considered the most important parasitic infection of the human central
nervous system and is estimated to cause between 20% and 50% of all late-onset epilepsy
cases globally (Bern et al., 1999). Epilepsy is a syndrome with considerable social, psychological,
economical and physical impact in a community, and affected individuals and their families are
often stigmatized, leading to decreased productivity and increased costs to the society. Taenia
solium requires humans and pigs as definitive and intermediate hosts, respectively, to complete
its life cycle. The larval stage of the parasite can cause disease in both humans and pigs with
potentially large economical impact in areas where the disease is endemic. In areas where meat
inspection is present, infected pig carcasses are totally or partially condemned, leading to impor-
tant income losses to the pig’s owner. These losses are also likely to impact on local, regional,
national and even international trade.  
The probability of a person being diagnosed or treated for NCC, the impact of the disease on
his/her productivity and the probability of affected pig carcasses being condemned are likely to
vary nationally and internationally.  The costs associated with these elements are also likely to
vary. Until recently there has been no concerted effort to assess these probabilities and costs on
a global scale, and therefore a thorough assessment of the burden of disease and impact of T.
solium cysticercosis has been impeded (Engels et al. 2003). Because this information was previ-
ously unavailable, NCC remains a “neglected” disease at the global level in spite of evidence indi-
cating that it is a significant problem in many poor countries around the world. 
The purpose of this ananlysis is to estimate the societal monetary burden of cysticercosis in
the Eastern Cape Province, South Africa, Honduras, India and the United States of America.
Materials and Methods
Epidemiological data Quantifying the monetary burden of cysticercosis requires obtaining valid
data on the frequency of infection and on associated morbidity outcomes in both human and pig
populations and their associated costs. In pigs, most economical losses occur when pigs are con-
demned in slaughterhouses. To our knowledge, there are no productivity losses associated with
porcine infection. The major health consequences to humans of cysticercosis infection occur with
NCC. The most common symptom is seizures, and an unknown proportion of persons with NCC
will go on to develop chronic, remote symptomatic seizures (i.e. epilepsy). Thus, epilepsy was
chosen as the primary outcome for the burden assessment. Data on the prevalence of cysticerco-
sis infection, NCC or epilepsy in each of the 4 study countries were obtained from a variety of
sources; most came from published sources, but some unpublished data and experts’ opinions
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were also used.  When determining which data to use, preference was given to studies done in
well defined, representative samples of a population, that used appropriate and fully described
serological methods, clearly stated and accepted definitions of epilepsy, and neuroimaging
assessments for NCC. Information on population frequencies of infection with cysticercosis and
associated diseases was gathered and organized with decision trees (Haddix, 2003, Pettiti, 2000;
Carabin et al., 2005). Figure 1 illustrates an example of a decision tree estimating the monetary
burden of human cysticercosis in Honduras.
Costs data We used a societal approach to value the monetary burden of T. solium cysticercosis,
which means that cysticercosis is assumed to have a monetary burden to all the individuals of a
population. The monetary effects of human losses are very useful indicators because, in the case
of zoonoses, they can be combined with the concomitant animal health and production losses to
estimate the total economic losses to society.  
Animal health costs Direct costs of cysticercosis infection in pigs will most often result in the
condemnation of the whole carcass at the slaughterhouse (Zoli et al., 2003). However, in poor
countries most pigs are slaughtered without any meat inspection (Joshi et al., 2003) and some
parts of the infected animals may still be sold, usually at a lower price (Zoli et al., 2003). This infor-
mation was very difficult to gather and estimates had to be made by our local collaborators in
most cases. In some instances, pigs are not sent to the abattoir at all, because in areas where
cysticercosis is endemic the carcasses would be rejected. In such situations there is a missed
opportunity for the farmers to improve their financial wellbeing. We did not attempt to estimate
any indirect cost associated with porcine cysticercosis as there is, to our knowledge, no available
data on the effect of T. solium on swine productivity in terms of growth, fertility and/or fecundity.
Human health costs We divided the human monetary burden into health provider costs (HPC)
and non-health provider costs (non-HPC). An effort was made to include all costs associated with
the diagnosis, treatment and follow-up of theoretical “average” cases who would not seek med-
ical attention, those who would seek medical attention, and those who would be hospitalised in
each country. Non-HPC represent out-of-pocket money that patients loose due to their conditions.
We used the average salary of a farmer to estimate the productivity losses, assuming that the
majority of cases of NCC would be living in small holder farming communities. We attributed the
same average salary for men and women and to mothers of affected children. Throughout, we
estimated the costs of NCC for one year. In all countries, if costs data were available from a previ-
ous year, they were updated to their current values using local health CPI for HPC (when avail-
able) and average CPI for salaries.  Updated values were then transformed to 2004 US dollars
using average 2004 currency exchange values.
Uncertainty and sensitivity analyses Estimates of the frequency of porcine or human cysticer-
cosis from epidemiological studies or national data are very uncertain. We carefully reviewed the
literature to identify the study population and source population in order to avoid an overestima-
tion of the national prevalence of the infection for the countries reviewed.  There is also a large
amount of uncertainty related to the proportion of infected cases that will develop different symp-
toms or experience productivity losses, mainly because no cohort or nested case-control studies
have been conducted to date to estimate these values. This is true for animal and human cases.
Finally, the monetary values attributed to the diagnosis and treatment of each symptom and, for
example, the daily salary of a farmer or a homemaker in a low-income country that would be lost
with a reduction in productivity, are always uncertain. To deal with the uncertainty inherent in the
available data, we used @Risk which is an add-in to Excel that uses Monte Carlo sampling to rep-
resent the uncertainty.  
Results Table 1 shows HPC, non-HPC and overall costs estimated for Honduras, India, Eastern
Cape Province, South Africa and the United States of America. In India, the human health sector
costs were estimated using three methods, two of which used estimates of the costs of epilepsy
previously published (Sawhney et al., 1996; Thomas et al., 2001). The third method was based on
epidemiological and costs estimates provided by one of the co-authors (VR).  
In all the sensitivity analyses, one of the most influential parameters was the proportion of active
epilepsy cases and/or seizure cases due to NCC. This parameter should be a priority in future
research in order to obtain better estimates based on clearly defined and validated diagnoses. Since
this proportion is likely to vary from country to country, such studies may need to be conducted on
a country-by-country basis.  Another parameter of interest is the prevalence of epilepsy, which has
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not been measured very well in communities other than the U.S.. We have made an effort in this
analysis to use estimates of the prevalence of epilepsy derived from the whole community.  Finally,
the time loss associated with epilepsy and NCC needs to be better estimated.
Discussion This study is the first to report a comprehensive estimate of the monetary burden of
cysticercosis on the health and agricultural sectors in 4 regions of the world (Latin America, North
America, Africa and Asia).  
The estimate of the monetary burden for Honduras is equivalent to 1% of the purchasing
power parity per capita. This is an enormous burden for these people. In Eastern Cape Province,
South Africa, our estimate of the monetary burden per capita is US$ 3.49, which is considerable
when compared to annual health expenditures of US$ 41.26 for people living in poor dwellings in
Eastern Cape Province (Statistics South Africa 2004). The estimate of the burden for India was not
as important on a per capita basis, but the absolute value of the monetary burden was impressive
(US$ 634 million). In addition, if we consider that 93% of Indians are Hindus and Muslims (CIA,
2004) and do not consume pork meat, those that do eat pig meat must be spreading the infection
very efficiently. The estimate from the United States was negligible compared to the wealth of
most of its citizens. However, most of the cases are immigrants for whom NCC could be devas-
tating financially. The only other recent value of the monetary burden for Africa is a very rough
estimate of losses associated with porcine cysticercosis in Cameroon (Zoli et al. 2003). These
authors estimated that with a nationwide prevalence of porcine cysticercosis of 9.25% and
assuming the value of each infected pig was reduced by 50, the total losses associated with
porcine cysticercosis were 2,062,125 (US$2,334,490) in 2003.  This is less than our average
annual estimate of US$5 million for Eastern Cape Province.  
This analysis has several limitations.  Few well-designed community-based epidemiological
studies have been published, resulting in very uncertain estimates for the epidemiological data.
Information on treatments received by NCC cases and their work loss were mostly based on
experts’ opinions due to the lack of published data. We included known ranges of uncertainty for
the economical data, but more needs to be done to improve these estimates. Estimates of work
lost are also extremely difficult to obtain. Reduction in the value of pig carcasses is not known, has
not been systematically measured, and may vary from place to place. Considering the increasing
trend of pig keeping and pork consumption in many developing countries, the burden and impact
of cysticercosis are expected to increase even further in the coming years. Another limitations is
that in most instances, the only costs to humans that were considered were those associated with
epilepsy. Other neurological manifestations of NCC, although less common, may also carry a signif-
icant societal burden, but these were generally not included in the estimates due to the absence
of useable data relating to the other manifestations of NCC. Therefore, we believe that our esti-
mates are conservative and that the true impact of cysticercosis may be even greater.
Conclusions Human and porcine cysticercosis is a preventable infection that produces monetary
burden to both agricultural and public health sectors for some regions of the world. More needs
to be done to raise awareness and encourage collaborations between these two sectors to con-
trol this preventable cause of epilepsy.
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Country Sector
Health Provider
costs
Non-health
Provider costs
Total Costs
Honduras
Agricultural 0.7 (0.4-1.3)
Health 6.9 (1.9-15.6) 11.3 (3.1-23.5) 18.2 (5.5-36.8)
Societal 19.0 (6.2-37.6)
India–Thomas estimates Health 50.6 (35.7-29.9) 164.8 (116.5-97.9) 215.4 (128.2-152.2)
India–Sawhney estimates Health 82.9 (58.6-49.1) 98.2 (69.3-58.1) 181.1 (107.2-127.9)
India – Our estimates
Agricultural 40.8 (1.9-95.7)
Health 23.7 (7.0-38.7) 70.1 (11.9-181.3) 93.8 (21.4-213.0)
Societal 134.6 (45.3-262.3)
Eastern Cape, South
Africa
Agricultural 5.0 (2.4-8.1)
Health 6.0 (2.3-11.3) 13.9 (2.9-35.7) 19.8 (6.2-43.6)
Societal 24.8 (10.5-49.1)
United States of America Health 1.0 (0.6-1.6) 2.1 (0.5-4.9) 3.1 (1.2-6.4)
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Figure 1. Example of a decision tree used for estimating the
monetary burden of Taenia solium cysticercosis in Honduras.
Table 1. Estimates of the average and 95% Credible Interval health provider (direct) and non-
health provider (indirect) and overall monetary burden (in millions of 2004 US$) of Taenia solium
cysticercosis in Honduras, India, Eastern Cape Province of South Africa and the USA.
